Literature DB >> 2381164

Renal handling of free sialic acid in normal humans and patients with Salla disease or renal disease.

R Seppala1, M Renlund, I Bernardini, F Tietze, W A Gahl.   

Abstract

The renal handling of free sialic acid, a negatively charged sugar, was investigated in normal humans and in patients with impaired sialic acid metabolism or impaired renal function. A sensitive assay for sialic acid, based upon the specific degradation of free sialic acid by N-acetylneuraminic acid aldolase, was developed to measure small amounts of sialic acid in human plasma. Using this assay on plasma from patients with disorders of sialic acid metabolism, we determined that the fractional excretion of sialic acid was maintained at approximately 98% over a wide range of filtered loads, i.e., from 40 to 2617 nmoles/minute. In other patients with different degrees of renal insufficiency, free sialic acid clearance varied directly with creatinine clearance, indicating filtration of this sugar by renal glomeruli. In patients with renal Fanconi syndrome, the urinary excretion of free sialic acid was independent of the severity of the generalized tubular defect, indicating that sialic acid was not reabsorbed by renal tubular cells. These findings indicate that sialic acid is filtered but not reabsorbed by the human kidney, in contrast with the handling of other sugars known to be reabsorbed by renal tubular cells. In addition, three of eight patients with Salla disease, a storage disorder due to impaired lysosomal transport of free sialic acid, were found to have reduced creatinine clearances, but all Salla disease patients had entirely normal renal tubular function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2381164

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.

Authors:  Jamshid Roozbeh; Ahmad Merat; Farahnaz Bodagkhan; Raha Afshariani; Hooman Yarmohammadi
Journal:  Int Urol Nephrol       Date:  2011-01-05       Impact factor: 2.370

2.  Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme.

Authors:  R Seppala; V P Lehto; W A Gahl
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Salla disease variant in a Dutch patient. Potential value of polymorphonuclear leucocytes for heterozygote detection.

Authors:  G M Mancini; P Hu; F W Verheijen; O P van Diggelen; H C Janse; W J Kleijer; F A Beemer; F G Jennekens
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

4.  Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H2S availability.

Authors:  Marta Martin-Lorenzo; Laura Gonzalez-Calero; Angeles Ramos-Barron; Maria D Sanchez-Niño; Carlos Gomez-Alamillo; Juan Manuel García-Segura; Alberto Ortiz; Manuel Arias; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  J Mol Med (Berl)       Date:  2017-10-04       Impact factor: 4.599

5.  Elevated plasma free sialic acid levels in individuals with reduced glomerular filtration rates.

Authors:  Federico Fuentes; Nuria Carrillo; Kenneth J Wilkins; Jodi Blake; Petcharat Leoyklang; William A Gahl; Jeffrey B Kopp; Marjan Huizing
Journal:  Kidney360       Date:  2020-09-24

6.  Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study.

Authors:  Susan Sparks; Goran Rakocevic; Galen Joe; Irini Manoli; Joseph Shrader; Michael Harris-Love; Barbara Sonies; Carla Ciccone; Heidi Dorward; Donna Krasnewich; Marjan Huizing; Marinos C Dalakas; William A Gahl
Journal:  BMC Neurol       Date:  2007-01-29       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.